Posted On: May 12, 2009
Recent company news reports that BioAstin® Natural Astaxanthin reduced C-reactive protein in a double blind, placebo controlled human clinical trial. The treatment group’s average CRP level went down an impressive 20.7% in just 8 weeks when taking BioAstin. Analysis of the results showed that they were statistically significant.
C-reactive protein is a key measurement of systemic or “silent” inflammation. “Silent” inflammation is inflammation that is present at low levels in the body for an extended period of time. Continued exposure to silent inflammation is theorized to be a root cause of a multitude of life threatening diseases. The American Heart Association has suggested that testing CRP levels in the blood may be a new measurement to assess cardiovascular disease risk. The independent researcher who completed this study said, “Other research suggests that systemic or silent inflammation may be implicated in many other life threatening diseases such as cancer, heart disease, stroke, diabetes and Alzheimer’s among others.”
More Info
